Growing Investment Portfolio Cherrystone Angel Group has demonstrated a strong track record with over $25 million invested across 26 companies and participation in more than 80 funding rounds raising over $250 million, indicating their active engagement and potential for further investment opportunities.

Focus on Healthcare Innovation Their recent investment in Lenoss Medical, a biomedical startup addressing osteoporotic spinal fractures, highlights a strategic focus on healthcare and life sciences, suggesting potential interest in cutting-edge medical technologies and startups.

Market Positioning As a leading angel group in New England and New York with a notable presence and recent successful exits like Medumo and Streamroot, they are well-positioned to discover and fund innovative startups, especially in regional tech and health sectors.

Tech and Digital Presence Utilizing a modern tech stack, including Squarespace, jQuery, and Vimeo, indicates they value digital engagement and online presence, offering opportunities to collaborate through digital platforms and content marketing.

Financial Health & Collaboration With an estimated revenue between 10 to 25 million dollars and active participation in multiple funding rounds, Cherrystone is financially robust and open to forming new strategic partnerships to expand their investment footprint.